News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,876 Results
Type
Article (40112)
Company Profile (271)
Press Release (661493)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205113)
Career Advice (2021)
Deals (35539)
Drug Delivery (97)
Drug Development (81251)
Employer Resources (172)
FDA (16211)
Job Trends (14919)
News (346500)
Policy (32654)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49782)
ALS (88)
Alzheimer's disease (1386)
Antibody-drug conjugate (ADC) (127)
Approvals (16216)
Artificial intelligence (255)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11659)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (279)
Cancer (2264)
Cardiovascular disease (174)
Career advice (1689)
Career pathing (30)
CAR-T (153)
Cell therapy (429)
Cervical cancer (19)
Clinical research (66121)
Collaboration (841)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2604)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2207)
Decentralized trials (2)
Denatured (20)
Depression (43)
Diabetes (271)
Diagnostics (6390)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86766)
Editorial (38)
Employer branding (21)
Employer resources (146)
Events (112949)
Executive appointments (729)
FDA (17476)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (106)
Generative AI (19)
Gene therapy (303)
GLP-1 (713)
Government (4433)
Grass and pollen (4)
Guidances (67)
Healthcare (18839)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16542)
IRA (43)
Job creations (3669)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (475)
Leadership (17)
Legal (7944)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (67)
Medical device (13389)
Medtech (13394)
Mergers & acquisitions (19541)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1924)
NextGen: Class of 2025 (6552)
Non-profit (4492)
Now hiring (39)
Obesity (364)
Opinion (208)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57641)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20620)
Phase II (29124)
Phase III (21683)
Pipeline (1203)
Policy (143)
Postmarket research (2564)
Preclinical (8773)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5954)
Recruiting (65)
Regulatory (22353)
Reports (46)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (133)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3632)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (30)
Vaccines (691)
Venture capitalists (43)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (156)
Last 7 days (937)
Last 30 days (2641)
Last 365 days (32887)
2025 (10776)
2024 (35331)
2023 (40180)
2022 (51290)
2021 (55839)
2020 (54154)
2019 (46647)
2018 (35133)
2017 (32231)
2016 (31637)
2015 (37719)
2014 (31464)
2013 (26511)
2012 (28776)
2011 (29431)
2010 (27525)
Location
Africa (724)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38067)
Australia (6237)
California (6158)
Canada (2017)
China (524)
Colorado (268)
Connecticut (274)
Delaware (148)
Europe (81785)
Florida (912)
Georgia (206)
Idaho (58)
Illinois (539)
India (26)
Indiana (310)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4584)
Michigan (220)
Minnesota (391)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1728)
New Mexico (28)
New York (1748)
North Carolina (968)
North Dakota (8)
Northern California (2688)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1103)
South Carolina (23)
South Dakota (1)
Southern California (2314)
Tennessee (101)
Texas (911)
United States (23196)
Utah (180)
Virginia (147)
Washington D.C. (63)
Washington State (555)
West Virginia (3)
Wisconsin (54)
701,876 Results for "crown biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Crown Bioscience and NEXT Oncology Cement Partnership Extension
May 1, 2025
·
3 min read
Press Releases
Crown Bioscience Appoints John Gu as Chief Executive Officer
March 13, 2025
·
3 min read
Press Releases
AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies
April 29, 2025
·
4 min read
Biotech Beach
Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services
Crown Bioscience today announced the dual attainment of College of American Pathologists (CAP) accreditations for its medical laboratory services.
April 11, 2024
·
2 min read
Press Releases
Crown Laboratories Completes Acquisition of Revance Therapeutics
February 7, 2025
·
3 min read
Press Releases
Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics
February 6, 2025
·
4 min read
Press Releases
Crown Laboratories Announces Appointment of Adelle Walker as Chief Marketing Officer, Aesthetics
February 27, 2025
·
3 min read
Press Releases
Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
February 5, 2025
·
5 min read
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
·
2 min read
·
Tristan Manalac
Biotech Beach
Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, will showcase significant contributions in preclinical and translational oncology research at the American Association for Cancer Research (AACR) 2024 meeting.
March 28, 2024
·
2 min read
1 of 70,188
Next
